The global radiation oncology market size was valued at USD 10.21 billion in 2024 and is projected to reach USD 28.07 billion ...

Aethlon Medical has enrolled the first patient in its Australian clinical trial evaluating the safety, feasibility, and ...

Johnson & Johnson shows strong progress in oncology with Darzalex sales and regulatory filings, leading to a 'Buy' rating ...

SUNY Poly Assistant Professor Dr. Amit Sangwan and colleagues recently published research titled "Feasibility Testing of the ...

University of B.C. researchers have developed a coating that could make medical devices safer for millions of patients, ...

The health-tech industry’s long-term growth is fueled by the growing need for cutting-edge technologies to address critical ...

The global companion diagnostics for oncology market size was US$ 2.9 billion in 2021. The global companion diagnostics for oncology market is forecast to grow to US$ 9.1 billion by 2030 by ...

We have patented the core of what we do, supporting a powerful no-code/low-code definition layer that enables an ecosystem of tools-like real-time, device-accurate previews ... studies in therapeutic ...

A team from Morgantown, W.Va.-based WVU Cancer Institute has become the first in the world to commercially use a new, FDA-approved medical device designed to lower the risk of esophageal cancer.

The FDA approved zolbetuximab (Vyloy) on October 18, 2024, as a first-line treatment for locally advanced unresectable or ...

Susan K. Bohnenkamp, an oncology clinical nurse specialist, is recognized for her compassionate and expert care, going above and beyond to support her patients through their cancer journey.